Processa Pharmaceuticals Inc (PCSA)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -56.981 | -27.87 | -79.863 | -44.228 | -156.333 | -154.397 |
| Return on Equity (%) | -77.621 | -37.914 | -93.138 | -47.2 | -166.428 | -178.523 |
| Return on Invested Capital (%) | -17.887 | -35.486 | -92.567 | -46.825 | -118.191 | -184.079 |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | -0.042 | 1.334 | 1.109 | 0.467 | 0.203 |
| Earnings Per Share | N/A | -0.087 | -1.364 | -0.727 | -1.715 | -0.452 |
| Cash Per Share | N/A | 0.018 | 1.459 | 1.05 | 0.407 | 0.191 |
| Working Capital Per Share | N/A | -0.005 | 1.418 | 1.104 | 0.462 | 0.199 |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | -0.103 | -1.459 | -0.761 | -1.715 | -0.452 |
| EBITDA Per Share | N/A | -0.103 | -1.459 | -0.761 | -1.715 | -0.452 |
| Free Cash Flow Per Share | N/A | -0.108 | -1.44 | -0.777 | -1.764 | -0.451 |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 2.06M |
| Price to Earnings Ratio | -0.18 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.43 |
| Price to Book Ratio | 0.41 |
| Dividend Yield | - |
| Shares Outstanding | 3.27M |
| Average Volume (1 week) | 1.53M |
| Average Volume (1 Month) | 511.69k |
| 52 Week Change | -74.22% |
| 52 Week High | 3.305 |
| 52 Week Low | 0.47 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
